Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sweetch Health
Ramat Gan, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Sweetch Health provides a commercially available AI- and behavioral science–driven digital therapeutics platform that delivers hyper‑personalized recommendations to improve adherence and outcomes in chronic disease management (e.g., medication adherence, physical activity, weight, and other lifestyle factors), used by health systems and industry partners such as Johns Hopkins University, Grupo Fleury, and Bayer.[2][4][6]
- Therapeutic areas
- OtherEndocrinologyImmunologyCardiovascular
- Modalities
- Non-pharmacological therapyDeviceSoftwareDigital therapeutic
- Industry
- Digital Health Medical Devices
02
Partnerships
Johns Hopkins UniversityGrupo FleuryBayer
Beyond the preview
Go deeper on Sweetch Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sweetch Health.